Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02602080
Other study ID # 2015-397
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2015
Est. completion date April 2016

Study information

Verified date September 2019
Source Hospital for Special Surgery, New York
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Nausea after surgery may negatively influence patient satisfaction, may delay discharge, and cause unexpected hospital admissions. The trend toward ambulatory surgery has increased the focus on postoperative nausea, but published evidence is not based on standardized criteria for assessment. Therefore, the results for postoperative nausea are very diverse, especially reports on nausea incidence after regional anesthesia, i.e. spinal anesthesia. When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving general anesthesia (GA) and nerve blocks are thought likely to have less nausea than patients receiving GA alone. This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. The results of this study will help power a future randomized controlled trial, comparing the incidence and intensity of nausea in FA patients receiving GA through laryngeal mask airway (LMA) versus spinal anesthesia.


Description:

Nausea after surgery may negatively influence patient satisfaction, may delay discharge, and cause unexpected hospital admissions. The trend toward ambulatory surgery has increased the focus on postoperative nausea, but published evidence is not based on standardized criteria for assessment. Therefore, the results for postoperative nausea are very diverse, especially reports on nausea incidence after regional anesthesia, i.e. spinal anesthesia. This is due to varying data sources, such as nurse notes and/or patient reports, and a lack of a consistent antiemetic and pain medication protocol. The results of this study will help power a future randomized controlled trial, comparing the incidence and intensity of nausea in FA patients receiving GA through laryngeal mask airway (LMA) versus spinal anesthesia.

When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving GA and nerve blocks are thought likely to have less nausea than patients receiving GA alone, due a reduction in pain leading to reduction in need for emetogenic opioids.

This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. At the author's institution, TSA is commonly performed with a brachial plexus block and either GA or intravenous sedation. TSA patients represent a model system for the effect of GA on nausea among patients receiving nerve blocks.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date April 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Elective surgery

- Age 18-99

- Patients who are capable to provide informed consent and answer questions in English,

- For FA patients: Planned neuraxial anesthesia + nerve block for postsurgical analgesia,

- For TSA patients: Planned brachial plexus nerve block + either general anesthesia or IV sedation.

Exclusion Criteria:

- Incapable to provide informed consent

- Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)

- Anticipated difficult airway

- Body mass index>35

- Anticipated surgical procedure time less than 1 hour or more than 4 hours,

- History of severe postoperative nausea and/or vomiting

- American Society of Anesthesiologists physical status classification >3

- Neuropathy

- Pregnant or nursing women

- Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions)

- Prone position planned for surgery

- Obstructive sleep apnea

- Known allergy/sensitivity to any study medications

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hospital for Special Surgery, New York New York New York

Sponsors (1)

Lead Sponsor Collaborator
Hospital for Special Surgery, New York

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Nausea 1 Hour After Post-anesthesia Care Unit (PACU) Admission Yes/no response to whether patient had nausea in the PACU 1 hour after admission. If yes, investigators will seek out intensity 1 hour after surgery
Primary Number of Participants With Nausea Yes/no question. If yes, the investigators will then seek intensity of nausea. Average 2 hours after surgery (at discharge from the recovery room after surgery)
Primary Intensity of Nausea On an 11 grade Likert scale (0=no nausea, 10=worst possible nausea) 1 hour after surgery
Primary Intensity of Nausea On a 11 grade Likert scale (0=no nausea, 10=worst possible nausea) 2 hours after surgery
Secondary Antiemetic Consumption Yes/no question if antiemetic consumption occured. Duration of stay in recovery room after surgery (average 2 hours)
Secondary Number of Participants With Emesis Yes/no question. If yes, the investigators will then seek intensity of emesis 1 hour after surgery
Secondary Number of Participants With Emesis Yes/no question. If yes, the investigators will then seek intensity of emesis Average 2 hours after surgery (at discharge from the recovery room after surgery)
Secondary Number of Participants Satisfied With Anesthesia Lowest satisfaction score on a 11 grade Likert scale (0=no satisfaction, 10=maximal satisfaction). PACU before discharge, an average of 2 hours
Secondary Patients Receiving Opioids in the PACU Yes/no for patients that were given opioids for pain management in the PACU. If opioids were consumed, the oral morphine equivalents for the patients taking opioids was totaled. PACU stay before discharge (average 2 hours)
Secondary Opioid Dose Among Patients Receiving Opioids in the PACU Total opioid dose taken by patients who took any opioids in the PACU, measured in oral morphine equivalents (mg OME) Duration of PACU stay (Average 2 hours)
See also
  Status Clinical Trial Phase
Terminated NCT01649258 - Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy Phase 1
Completed NCT02939287 - Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan Phase 3
Not yet recruiting NCT06055192 - Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022
Recruiting NCT04091789 - Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase 2
Completed NCT02462811 - A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV) Phase 3
Completed NCT01007500 - Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery Phase 4
Recruiting NCT00528554 - Laser Acupuncture Against Nausea in Children N/A
Completed NCT00537875 - Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens N/A
Completed NCT00394966 - A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED) Phase 2
Completed NCT00946387 - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions Phase 1
Completed NCT00947128 - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions Phase 1
Recruiting NCT05433636 - Mindful Waiting Room N/A
Not yet recruiting NCT04827108 - Psychometric Properties of the Chinese Version of PeNAT
Not yet recruiting NCT04853303 - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK N/A
Terminated NCT04247100 - A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders N/A
Recruiting NCT04181346 - Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting Phase 2
Recruiting NCT03679182 - Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care Phase 2
Completed NCT02618343 - EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron N/A
Terminated NCT01405924 - Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030) Phase 2
Recruiting NCT04116697 - A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan N/A